Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;42(6):1259-1267.
doi: 10.1111/liv.15188. Epub 2022 Mar 11.

The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint

Taghreed M Farahat  1 , Mehmet Ungan  2 , Josep Vilaseca  3   4   5 , Jacqueline Ponzo  6 , Pramendra Prasad Gupta  7 , Andrew D Schreiner  8 , Wadeia Al Sharief  9 , Kelly Casler  10 , Tafat Abdelkader  11 , Ludovico Abenavoli  12 , Fatima-Zohra Mchich Alami  13 , Mattias Ekstedt  14 , Muntadar S Jabir  15 , Matthew J Armstrong  16 , Mona H Osman  17 , Johannes Wiegand  18 , Dina Attia  19 , Veronique Verhoeven  20 , Ashraf Abdul Qayoum Amir  21 , Nagwa N Hegazy  1 , Emmanuel A Tsochatzis  22 , Yasser Fouad  23 , Helena Cortez-Pinto  24
Affiliations
Review

The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint

Taghreed M Farahat et al. Liver Int. 2022 Jun.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Liu J, Ayada I, Zhang X, et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol H. 2022;20(3):e573-e582. doi: 10.1016/j.cgh.2021.02.030
    1. Eslam M, Fan J-G, Mendez-Sanchez N. Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health. Lancet Gastroenterol Hepatol. 2020;5:713-715.
    1. Ye Q, Zou B, Yeo YH, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:739-752.
    1. Eslam M, Sarin SK, Wong VW, et al. The Asian Pacific Association for the Study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14(6):889-919.
    1. Shiha G, Alswat K, Al Khatry M, et al. Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and North Africa. Lancet Gastroenterol Hepatol. 2021;6(1):57-64.

LinkOut - more resources